Skip to main content
Signal8

Stuckley Carol

SEC insider (Form 3/4/5 filer). CIK 0001863298. Director at Centessa Pharmaceuticals plc (CNTA). 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 24, 2026. Located in CHESHIRE.

Companies Stuckley Carol has filed insider reports for

  • Centessa Pharmaceuticals plc (CNTA): Director
Stuckley Carol profile photo

Stuckley Carol

CIK: 0001863298

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)5 (83.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Centessa Pharmaceuticals plc logo
CNTA

Centessa Pharmaceuticals plc

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • Centessa Pharmaceuticals plc logo
    CNTA

    Centessa Pharmaceuticals plc

    Jun 24, 2026
    Disposition

    Share Option (right to buy)

    Direct
    208.5K shares-
  • Centessa Pharmaceuticals plc logo
    CNTA

    Centessa Pharmaceuticals plc

    Jun 24, 2026
    Disposition

    Share Option (right to buy)

    Direct
    48K shares-
  • Centessa Pharmaceuticals plc logo
    CNTA

    Centessa Pharmaceuticals plc

    Jun 24, 2026
    Disposition

    Share Option (right to buy)

    Direct
    48K shares-
  • Centessa Pharmaceuticals plc logo
    CNTA

    Centessa Pharmaceuticals plc

    Jun 24, 2026
    Disposition

    Share Option (right to buy)

    Direct
    48K shares-
  • Centessa Pharmaceuticals plc logo
    CNTA

    Centessa Pharmaceuticals plc

    Jun 24, 2026
    Disposition

    Share Option (right to buy)

    Direct
    40K shares-
  • Centessa Pharmaceuticals plc logo
    CNTA

    Centessa Pharmaceuticals plc

    Jun 20, 2025
    Award

    Share Option (right to buy)

    Direct
    40K shares-

1-6 of 6